Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001824293-25-000118
Filing Date
2025-08-14
Accepted
2025-08-14 16:58:34
Documents
1
Period of Report
2025-08-13

Document Format Files

Seq Description Document Type Size
1 FORM 4 wk-form4_1755205110.html 4  
1 FORM 4 wk-form4_1755205110.xml 4 3868
  Complete submission text file 0001824293-25-000118.txt   5521
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 208 LA JOLLA CA 92037 (619) 400-1171
GRI Bio, Inc. (Issuer) CIK: 0001824293 (see all company filings)

EIN.: 824369909 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 100 N. 18TH STREET SUITE 300 PHILADELPHIA PA 19103
Business Address
Baker David Charles (Reporting) CIK: 0001844060 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40034 | Film No.: 251220613